HRH4 and pulmonary fibrosis: Previous studies demonstrated that this receptor is involved in the pathogenesis of pulmonary fibrosis, and treatment with a highly selective H4R antagonist reduces pro-inflammatory and pro-fibrotic markers preventing fibrosis progression in a bleomycin-induced lung injury model [10, 11].